The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
Shanghai East Hospital · Second Affiliated Hospital of Zhejiang University · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
129
total citations
- FWCI
- 47.94
- Percentile
- 100%
- References
- 308
Citations per year
Authors
7Topics & keywords
Topics
Keywords
- Medicine
- Erlotinib
- Lung cancer
- Oncology
- Targeted therapy
- Tyrosine kinase
- Cancer
- Cancer research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.